Skip to main content

Advertisement

Table 2 Detection rates for the GynTect assay in different age groups. Especially the NILM group is very imbalanced between the age groups

From: Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages

<35y CxCa (n = 2) CIN3 (n = 22) CIN2 (n = 5) CIN1 (n = 3) NILM (n = 38)
# tested samples 2 22 5 3 38
# GynTect positive 2 12 2 0 0
# GynTect negative 0 9 3 3 37
# GynTect invalid 0 1 0 0 1
# valid samples 2 21 5 3 37
detection rate [%] 100.0% 57.1% 40.0% 0.0% 0.0%
≥ 35y CxCa (n = 3) CIN3 (n = 28) CIN2 (n = 14) CIN1 (n = 2) NILM (n = 163)
# tested samples 3 28 14 2 163
# GynTect positive 3 18 6 1 3
# GynTect negative 0 10 7 1 159
# GynTect invalid 0 0 1 0 1
# valid samples 3 28 13 2 162
detection rate [%] 100.0% 64.3% 46.2% 50.0% 1.9%